AAA
WHWK

Affinity Asset Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

Affinity Asset Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,019
Closed -$96.9K – 107
2024
Q3 		$96.9K Buy
+47,019
New +$76K 0.01% 84
2023
Q3 		– Sell
-187,675
Closed -$1.28M – 95
2023
Q2 		$1.28M Buy
+187,675
New +$1.46M 0.45% 44

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Affinity Asset Advisors's WHWK Position: Q4 2024 in Review

Affinity Asset Advisors sold out of Whitehawk Therapeutics (WHWK) in Q4 2024, closing a stake of 47,019 shares — an estimated $96.9K sold.

Affinity Asset Advisors first reported a position in WHWK in Q2 2023 and held it in 2 quarters. The position peaked at $1.28M in Q2 2023. 53 funds tracked by Wall St. Rank hold WHWK as of Q4 2024.

  • Affinity Asset Advisors reported no remaining Whitehawk Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 47,019 Whitehawk Therapeutics shares in Q4 2024, an estimated $96.9K.
  • Affinity Asset Advisors first reported a position in Whitehawk Therapeutics in Q2 2023 and held it in 2 quarters.
  • Affinity Asset Advisors's Whitehawk Therapeutics position peaked at $1.28M in Q2 2023.
  • 53 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2024.

Based on Affinity Asset Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.